| Product Code: ETC7055486 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Rivaroxaban Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Rivaroxaban Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Rivaroxaban Market - Industry Life Cycle |
3.4 Egypt Rivaroxaban Market - Porter's Five Forces |
3.5 Egypt Rivaroxaban Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Egypt Rivaroxaban Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Egypt Rivaroxaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Egypt |
4.2.2 Growing awareness about the benefits of using rivaroxaban for stroke prevention in patients with atrial fibrillation |
4.2.3 Favorable government initiatives promoting the use of novel oral anticoagulants like rivaroxaban |
4.3 Market Restraints |
4.3.1 High cost associated with rivaroxaban compared to traditional anticoagulants |
4.3.2 Limited accessibility to specialized healthcare facilities offering rivaroxaban treatment |
5 Egypt Rivaroxaban Market Trends |
6 Egypt Rivaroxaban Market, By Types |
6.1 Egypt Rivaroxaban Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Egypt Rivaroxaban Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Egypt Rivaroxaban Market Revenues & Volume, By Acute coronary syndrome, 2021- 2031F |
6.1.4 Egypt Rivaroxaban Market Revenues & Volume, By Pulmonary embolism, 2021- 2031F |
6.1.5 Egypt Rivaroxaban Market Revenues & Volume, By Venous thromboembolism, 2021- 2031F |
6.1.6 Egypt Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Egypt Rivaroxaban Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Egypt Rivaroxaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Egypt Rivaroxaban Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Egypt Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Rivaroxaban Market Import-Export Trade Statistics |
7.1 Egypt Rivaroxaban Market Export to Major Countries |
7.2 Egypt Rivaroxaban Market Imports from Major Countries |
8 Egypt Rivaroxaban Market Key Performance Indicators |
8.1 Number of new prescriptions for rivaroxaban |
8.2 Patient adherence rate to rivaroxaban treatment |
8.3 Number of healthcare providers trained in prescribing rivaroxaban |
8.4 Rate of adverse events reported related to rivaroxaban use |
9 Egypt Rivaroxaban Market - Opportunity Assessment |
9.1 Egypt Rivaroxaban Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Egypt Rivaroxaban Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Egypt Rivaroxaban Market - Competitive Landscape |
10.1 Egypt Rivaroxaban Market Revenue Share, By Companies, 2024 |
10.2 Egypt Rivaroxaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here